Megan Titas, M.D.
Internal Medicine Physician in Boston, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,737 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Megan Titas, M.D. reported a CMS MIPS final score of 79.8/100 - below the 83.5 national average - and filed 4,369 Medicare Part D claims in 2023.
- 79.8/100
- MIPS score · -4 vs avg
- 4K
- Part D claims, 2023
- 83%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1487820338 · Internal Medicine Physician
NPI-10 · ENUM-MID · TAX-MEGA · MIPS-BELOW · RX-MID · BOOK-MID · PHOTO-FINISH
- NPI-10 1487820338
- ENUM-MID 2008
- TAX-MEGA 173K Internal Medicine
- MIPS-BELOW 79.8/100
- RX-MID 4,369
- BOOK-MID 7,862 in Massachusetts
- PHOTO-FINISH Sheila Maier · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Titas · this pro…
Titas · this provider
79.8 MIPS pts
- Kenneth Afenya ·…
Kenneth Afenya
79.8 MIPS pts
- Sheila Maier · n…
Sheila Maier
79.8 MIPS pts
- Anthony Sherman …
Anthony Sherman
79.8 MIPS pts
- Martina Ziegenbe…
Martina Ziegenbein
79.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Megan Titas, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
80 ≥ 26th percentile 26% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Megan Titas, M.D. sits
This provider among internal medicine physician peers
Across the 34,612 internal medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Megan Titas, M.D. writes more Part D claims than 79% of them and scores higher on MIPS quality than 28% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one internal medicine physician peer from a representative sample of 60; the gold marker is Megan Titas, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Megan Titas, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Megan Titas, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Massachusetts
How Internal Medicine Physician compares to other specialties among Massachusetts providers
Internal Medicine Physician ranks #6 among Massachusetts's specialties (3.7% of in-state providers)
Each bar is a specialty's share of the Massachusetts provider total, by primary NUCC taxonomy. The highlighted bar is Internal Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Megan Titas, M.D.'s 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 79.8/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Internal Medicine Physician US NPIs
79.8/100 MIPS final score - 3.7 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician. Quality dim: 63.4.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1487820338 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 05/01/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Megan Titas, M.D.'s current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1487820338 is the unique 10-digit identifier CMS uses to link Titas across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Megan Titas, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Megan Titas, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$137
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Megan Titas, M.D.. To verify Megan Titas, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 4,369 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 11,177
- Total Day Supply
- 333,378
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $845K
- Generic Drug Cost
- $98K
- Antibiotic Claims
- 22
Patient Demographics
- Average Patient Age
- 77.2 years
- Avg HCC Risk Score
- 1.41
- Gender Split
- 54% female / 46% male
- Age Distribution
- <65: 20, 65-74: 233, 75-84: 293, 85+: 131
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Megan Titas, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
552 claims
- Metoprolol Succinate
Metoprolol Succinate
548 claims
- Eliquis
Eliquis
333 claims
- Lisinopril 219
Lisinopril
219 claims
- Xarelto 191
Xarelto
191 claims
- Amlodipine Besylate 187
Amlodipine Besylate
187 claims
- Losartan Potassium 152
Losartan Potassium
152 claims
- Rosuvastatin Calcium 148
Rosuvastatin Calcium
148 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 552 |
| Metoprolol Succinate | 548 |
| Eliquis Apixaban | 333 |
| Lisinopril | 219 |
| Xarelto Rivaroxaban | 191 |
| Amlodipine Besylate | 187 |
| Losartan Potassium | 152 |
| Rosuvastatin Calcium | 148 |
| Furosemide | 139 |
| Valsartan | 129 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Megan Titas, M.D. fits within the Internal Medicine Physician landscape nationally.
Megan Titas, M.D.'s 4,369 claims are above the specialty average of 2,716.
Nationwide Internal Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Titas, both outside Massachusetts so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (79.8 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Internal Medicine Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Titas.
One of 7,862 Internal Medicine Physician providers enrolled in Massachusetts, 5 are shown here.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Megan Titas, M.D.'s specialty? ▼
How much does Megan Titas, M.D. prescribe under Medicare Part D? ▼
What is Megan Titas, M.D.'s Medicare quality score? ▼
Where is Megan Titas, M.D. located? ▼
What is Megan Titas, M.D.'s NPI number? ▼
Does Megan Titas, M.D. prescribe more brand-name or generic drugs? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does Megan Titas, M.D. prescribe most often? ▼
Does Megan Titas, M.D. accept Medicare? ▼
How can I verify Megan Titas, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.